Literature DB >> 1709945

Reactivities of serotyping monoclonal antibodies with culture-adapted human rotaviruses.

R L Ward1, M M McNeal, J D Clemens, D A Sack, M Rao, N Huda, K Y Green, A Z Kapikian, B S Coulson, R F Bishop.   

Abstract

Rotaviruses collected in Bangladesh during 1985 to 1986 were culture adapted and used in a comparative serotyping study with three groups of monoclonal antibodies, all of which reacted with the major neutralization protein (VP7) of serotype 1, 2, 3, or 4. The goals were to determine which monoclonal antibodies most accurately predicted the serotype and why large variations in serotyping efficiencies have occurred with these monoclonal antibodies in previous studies. The 143 rotavirus isolates used in this study belonged to 69 different electropherotypes; and 44, 23, 21, and 55 isolates were identified as serotype 1 through 4, respectively, by neutralization with serotype-specific hyperimmune antisera. Serotyping specificity by enzyme-linked immunosorbent assay with monoclonal antibodies was 100% consistent with results found by neutralization with polyclonal antisera, but large differences were observed in the sensitivities of the different monoclonal antibodies. Monoclonal antibodies 5E8 (serotype 1), 1C10 (serotype 2), 159 (serotype 3), RV3:1 (serotype 3), ST-3:1 (serotype 4), and ST-2G7 (serotype 4) reacted with all the isolates of the corresponding serotype for which there were sufficient infectious particles. Monoclonal antibody 2F1 (serotype 2) was much less sensitive and reacted with only five serotype 2 isolates, but these were among those with the highest titers. Monoclonal antibodies RV4:2 (serotype 1), KU6BG (serotype 1), RV5:3 (serotype 2), and S2-2G10 (serotype 2), on the other hand, failed to react with between one and three isolates of the corresponding serotypes which had high titers, apparently because of epitope changes in these isolates. Effects of epitope variation were, however, most apparent with monoclonal antibodies 2C9 (serotype 1) and YO-1E2 (serotype 3), which reacted with one and no isolates of the corresponding serotypes, respectively. Cross-neutralization of escape mutants indicated that the serotype 1 monoclonal antibodies 5E8, 2C9, and RV4:2 reacted with different but probably overlapping epitopes, as did serotype 2 monoclonal antibodies 2F1, 1C10, and RV5:3, finding that were consistent with the enzyme-linked immunosorbent assay data. Because of epitope variations between rotavirus strains, serotyping with several monoclonal antibodies directed at different epitopes may increase the sensitivity of the method.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709945      PMCID: PMC269798          DOI: 10.1128/jcm.29.3.449-456.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  Use of serotype-specific monoclonal antibodies to study the epidemiology of rotavirus infection.

Authors:  C J Birch; R L Heath; I D Gust
Journal:  J Med Virol       Date:  1988-01       Impact factor: 2.327

2.  Comparative sensitivities of solid-phase immune electron microscopy and enzyme-linked immunosorbent assay for serotyping of human rotavirus strains with neutralizing monoclonal antibodies.

Authors:  G Gerna; A Sarasini; B S Coulson; M Parea; M Torsellini; E Arbustini; M Battaglia
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

Review 3.  Perspective on the development and deployment of rotavirus vaccines.

Authors:  R Edelman
Journal:  Pediatr Infect Dis J       Date:  1987-08       Impact factor: 2.129

4.  Antigenic characterization of rotaviruses isolated in Kenya from 1982 to 1983.

Authors:  T Urasawa; S Urasawa; Y Chiba; K Taniguchi; N Kobayashi; L N Mutanda; P M Tukei
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

5.  Efficiency of human rotavirus propagation in cell culture.

Authors:  R L Ward; D R Knowlton; M J Pierce
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

6.  Subgroups, serotypes, and electrophoretypes of rotavirus isolated from children in Bangui, Central African Republic.

Authors:  M C Georges-Courbot; A M Beraud; G M Beards; A D Campbell; J P Gonzalez; A J Georges; T H Flewett
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

7.  Occurrence of changes in human rotavirus serotypes with concurrent changes in genomic RNA electropherotypes.

Authors:  T Nakagomi; K Akatani; N Ikegami; N Katsushima; O Nakagomi
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

8.  Human-rhesus reassortant rotavirus vaccines: safety and immunogenicity in adults, infants, and children.

Authors:  N A Halsey; E L Anderson; S D Sears; M Steinhoff; M Wilson; R B Belshe; K Midthun; A Z Kapikian; R M Chanock; R Samorodin
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

9.  Identification of two subtypes of serotype 4 human rotavirus by using VP7-specific neutralizing monoclonal antibodies.

Authors:  G Gerna; A Sarasini; A di Matteo; M Parea; P Orsolini; M Battaglia
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

10.  Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants.

Authors:  J Flores; I Perez-Schael; M Gonzalez; D Garcia; M Perez; N Daoud; W Cunto; R M Chanock; A Z Kapikian
Journal:  Lancet       Date:  1987-04-18       Impact factor: 79.321

View more
  16 in total

1.  Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: emergence of type G9 in 1995.

Authors:  L E Unicomb; G Podder; J R Gentsch; P A Woods; K Z Hasan; A S Faruque; M J Albert; R I Glass
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  Comparisons of rotavirus VP7-typing monoclonal antibodies by competition binding assay.

Authors:  P Raj; D O Matson; B S Coulson; R F Bishop; K Taniguchi; S Urasawa; H B Greenberg; M K Estes
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

3.  Distribution of serotypes of human rotavirus in different populations.

Authors:  P A Woods; J Gentsch; V Gouvea; L Mata; M Santosham; Z S Bai; S Urasawa; R I Glass
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

4.  Maternal Helminth Infection Is Associated With Higher Infant Immunoglobulin A Titers to Antigen in Orally Administered Vaccines.

Authors:  Carolyn E Clark; Michael P Fay; Martha E Chico; Carlos A Sandoval; Maritza G Vaca; Alexis Boyd; Philip J Cooper; Thomas B Nutman
Journal:  J Infect Dis       Date:  2016-02-16       Impact factor: 5.226

5.  Analysis by rotavirus gene 6 reverse transcriptase-polymerase chain reaction assay of rotavirus-positive gastroenteritis cases observed during the vaccination phase of the Rotavirus Efficacy and Safety Trial (REST).

Authors:  David O Matson; Timo Vesikari; Penelope Dennehy; Michael D Dallas; Michelle G Goveia; Robbin F Itzler; Max Ciarlet
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

6.  Culture adaptation and characterization of group A rotaviruses causing diarrheal illnesses in Bangladesh from 1985 to 1986.

Authors:  R L Ward; J D Clemens; D A Sack; D R Knowlton; M M McNeal; N Huda; F Ahmed; M Rao; G M Schiff
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

7.  Serotype specificity of the neutralizing-antibody response induced by the individual surface proteins of rotavirus in natural infections of young children.

Authors:  G Menchaca; L Padilla-Noriega; M Méndez-Toss; J F Contreras; F I Puerto; H Guiscafré; F Mota; I Herrera; R Cedillo; O Muñoz; R Ward; Y Hoshino; S López; C F Arias
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

8.  VP4 genotyping of human rotavirus in the United States.

Authors:  N Santos; M Riepenhoff-Talty; H F Clark; P Offit; V Gouvea
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

9.  Isolation of a human rotavirus containing a bovine rotavirus VP4 gene that suppresses replication of other rotaviruses in coinfected cells.

Authors:  R L Ward; Q Jin; O Nakagomi; D S Sander; J R Gentsch
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

10.  Prevalence of G2P[4] and G12P[6] rotavirus, Bangladesh.

Authors:  Mustafizur Rahman; Rasheda Sultana; Giasuddin Ahmed; Sharifun Nahar; Zahid M Hassan; Farjana Saiada; Goutam Podder; Abu S G Faruque; A K Siddique; David A Sack; Jelle Matthijnssens; Marc Van Ranst; Tasnim Azim
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.